Positron Emission Tomography (PET) Scanners Growth, Trends & Forecast Outlook 2033

Positron Emission Tomography (PET) Scanners by Type (Full-Ring Pet Scanner, Partial-Ring Pet Scanner), by Application (Hospitals, Diagnostic Centers, Research Centers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $784.5 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $784.5 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Positron Emission Tomography (PET) Scanners Market Overview

Positron Emission Tomography (PET) Scanners—molecular-imaging platforms that visualize metabolic activity—have become mission-critical for oncology, neurology, and cardiology diagnostics. The Positron Emission Tomography (PET) Scanners market size is valued at US$ 2.4 billion in 2025 and is headed for sustained market forecast growth at a 6.1% CAGR through 2033, underpinned by rising cancer prevalence, accelerated uptake of value-based imaging, and hospital efforts to reduce downstream treatment costs. Global industry expansion is amplified by cyclotron-on-site programs, expanding reimbursement for amyloid PET, and the shift from standalone PET to hybrid PET/CT and PET/MR systems that tighten scan-time and boost throughput.

Loading chart…

North America retains the largest revenue share (>38%) on the strength of high procedural volumes and bundled-payment models, while Asia-Pacific is the fastest-growing region (>7% CAGR) as China and India scale up domestic radio-pharmaceutical capacity and insurance coverage. Technology shifts—silicon-photomultiplier (SiPM) detectors shortening scan duration, AI-driven reconstruction lowering dosages, and the emergence of total-body PET—are reshaping competitive dynamics and intensifying capital-equipment refresh cycles. Regulatory tightening around dose management and the global helium supply squeeze are forcing vendors to redesign magnet and cooling architectures, adding cost but also spurring service-based leasing models that mitigate hospital capex and accelerate growth outlook adoption worldwide.

Report Overview

Report Attribute	Details
Market size value in 2025	784.50 million
Revenue forecast in 2033	1.09 billion
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Siemens Healthineers; Koninklijke Philips N.V; Toshiba Corporation; Shimadzu Corporation; Hitachi Medical Corporation; Fujifilm Corporation; Neusoft Medical Systems; Sunny Medical Equipment; Nanjing Foinoe Co; Yangzhou Kindsway Biotech; Mindray Medical International; Shenzhen Anke High-Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Biomarker-centric oncology trials are shifting imaging endpoints from structural (CT/MR) to metabolic (PET), expanding protocol-mandated scanner demand; sponsors now budget for on-site PET to accelerate recruitment, enlarging the Positron Emission Tomography (PET) Scanners market size at an estimated 7–8 % CAGR through 2029.

New CMS coverage for amyloid-PET in Alzheimer’s diagnosis (effective 2022) removed prior prior-authorization friction, triggering a 30 % YoY uptick in U.S. Medicare claims and pushing hospitals to upgrade to high-silicon-photomultiplier digital systems to handle higher throughput.

Restraints

Capital budgets are being re-allocated to proton-therapy and surgical-robot programs; with average PET/CT prices still >US$1.4 mm, CFOs defer replacement cycles beyond seven years, compressing near-term unit sales in mature markets.

Regulatory harmonization lag between FDA-approved radiotracers and EMA/NMPA means OEMs must run three separate validation streams, extending launch timelines by 12–18 months and eroding price premiums in the Positron Emission Tomography (PET) Scanners market.

Opportunities

Theranostics expansion (Lu-177, Ac-225) favors long-axial-field-of-view total-body scanners that double as theranostic production suites; early adopters are capturing US$2 k+ per dose margins and locking in regional patient referral networks.

Bundled AI-driven cardiac viability packages (perfusion + flow reserve) allow outpatient imaging centers to bill US$1,850 per study—40 % above standard FDG protocols—creating a high-ROI upsell path that supports a mid-teens growth forecast in ambulatory settings.

Challenges

Mo-99 supply remains vulnerable; NRU reactor shutdown in Canada shifted global sourcing to South Africa and Australia, and any >30-day unplanned outage could idle up to 25 % of installed scanners, jeopardizing service-level agreements.

Competition from low-cost Chinese OEMs offering 70 % price discounts has compressed Western vendors’ gross margins to <35 %, forcing them to shift toward detector-as-a-service leasing models that lengthen cash-payback periods.

Market Segmentation

Loading chart…

Positron Emission Tomography (PET) Scanners segmentation by type is anchored in detector technology, where full-ring systems dominate installed capacity because their 360° coverage yields the highest true-coincidence count rate, translating into superior lesion detectability and premium pricing. Partial-ring designs lower component cost and weight, yet the need for detector rotation lengthens scan time and limits dynamic imaging, restricting share to niche budget-constrained settings. Hybrid architecture—PET/CT or PET/MRI—alters value perception: the combined modality shortens the diagnostic pathway, reduces patient visits, and justifies higher capital outlay; consequently, standalone PET units now account for <10% of new sales in developed markets.

Application-level market taxonomy reveals oncology as the volume driver, representing roughly four-fifths of global procedure billing owing to FDG-avid solid-tumour staging, therapy-response surveillance, and rising screening protocols for high-risk cohorts. Cardiology is the second, but much smaller, revenue pillar; the shift from SPECT to rubidium-82 or ammonia-N-13 PET perfusion studies offsets reimbursement pressure in the U.S. and Western Europe, keeping segment CAGR above 4%. Neurology is emerging, propelled by amyloid and tau imaging for Alzheimer’s diagnosis, yet remains price-sensitive with limited tracer availability; other indications (infection, paediatric metabolism) are collectively <5% of installed utilisation, constraining their share of the addressable Positron Emission Tomography (PET) Scanners market.

Positron Emission Tomography (PET) Scanners Segmentation Breakdown7 items

Type

Full-Ring Pet Scanner

Partial-Ring Pet Scanner

Application

Hospitals

Diagnostic Centers

Research Centers

Regional Insights

Loading chart…

North America dominates the Positron Emission Tomography (PET) Scanners market, accounting for ~38% share, driven by a mature reimbursement framework, high oncological referral rates, and rapid uptake of digital PET/CT. CMS coverage expansion for Alzheimer’s imaging is accelerating replacement demand, while venture-backed AI radiomics start-ups are integrating into hospital networks, reinforcing Positron Emission Tomography (PET) Scanners market growth.

Europe secures the second position, propelled by the EU Beating Cancer Plan allocating €4.2 bn for imaging infrastructure and the upcoming 2025 Euratom directive mandating dose-tracking. Western Europe is near-replacement mode, whereas Central & Eastern Europe is purchasing first-time systems, sustaining a mid-single-digit regional forecast. Germany and France lead installed base, but Poland and Czechia post fastest unit growth.

Asia Pacific is the fastest-growing region (CAGR >9%), underpinned by China’s National Cancer Prevention Action Plan, Japan’s dementia screening programme, and India’s 200+ new molecular imaging centres under PM-Ayushman. Heavy local manufacturing (United Imaging, Canon) compresses scanner prices 20-30%, while hospital groups in Tier-2 Chinese cities adopt 60-cm bore digital PET as a competitive differentiator.

Latin America is scaling through public-private partnerships; Brazil’s SUS reimbursed 23k PET scans in 2023 and is procuring 30 systems through 2026. Middle East & Africa growth is uneven—GCC states leverage sovereign funds for total-body PET research, yet Sub-Saharan utilisation is hindered by cyclotron shortages and volatile tracer imports.

Competitive Landscape

The Positron Emission Tomography (PET) Scanners competitive landscape is moderately consolidated, dominated by a handful of global OEMs that control core detector technology and hold established service networks across North America and Europe. Regional Chinese vendors are eroding price discipline in Asia-Pacific through 20-40% lower list prices, forcing incumbents to bundle extended warranty and software upgrades to protect margin. Pricing therefore remains the primary competitive lever, followed by speed of 510(k) and CE approvals, breadth of detector crystal options, and ability to co-market with cyclotron and radiopharmacy partners.

To escape pure price competition, manufacturers pursue vertical integration—acquiring radiopharmacy start-ups or dosimetry software firms—to lock in downstream revenue and increase switching costs. Others localize production in India, Brazil, or Turkey to circumvent import duties and shorten delivery cycles, accepting higher compliance costs as trade regulations tighten. A shared challenge is the commoditization of basic time-of-flight capability, which depresses gross margins and pushes vendors toward premium, high-resolution digital photon counting platforms or subscription-based imaging-as-a-service models.

Companies Strategy Snapshot6 items

GE Healthcare: premium digital photon counting pipeline to protect ASPs

Siemens Healthineers: vertical integration with radiopharmacy acquisitions

Koninklijke Philips N.V: service contracts bundling AI reconstruction software

Toshiba Corporation: local manufacturing in India to bypass import duties

Mindray Medical International: cost-down design targeting price-sensitive Tier-2 hospitals

Neusoft Medical Systems: regional expansion through government tender partnerships

Market Ecosystem

The Positron Emission Tomography (PET) Scanners ecosystem stretches from radioisotope suppliers and detector component vendors upstream, through scanner OEMs and software integrators at midstream, to distributors, service providers, and imaging centers or hospitals downstream. Value is created by translating cyclotron-generated isotopes and detector signals into clinically actionable images; it is captured by players that secure regulatory approvals, ensure uptime, and bundle financing with after-sales support.

Ecosystem Participants7 items

Radiopharmaceutical producers — synthesize and distribute PET isotopes with short half-lives to scanning sites.

Detector component suppliers — provide scintillation crystals, photodetectors, and electronics that determine spatial resolution.

Scanner OEMs — integrate detectors, gantries, and reconstruction software into certified PET/CT or PET/MR systems.

Reconstruction & AI software vendors — license iterative algorithms and deep-learning tools enhancing lesion detectability and scan speed.

Distributors & leasing partners — finance, warehouse, and resell scanners while managing hospital procurement cycles.

Service & refurbishment providers — perform installation, preventive maintenance, detector re-crystalization, and end-of-life remarketing.

Imaging departments & academic centers — operate scanners, recruit patients, and interpret studies to guide therapy decisions.

Control points reside with OEMs that lock image reconstruction to proprietary hardware, and with producers that hold regional isotope supply contracts; shortages of high-purity ^18^F-FDG or crystal components can idle entire fleets. Switching costs are high because hospitals rely on long-term service agreements, specialized room shielding, and trained technologists, while interoperability standards such as DICOM and HL7 still leave vendor-specific data formats that complicate multi-vendor fleet integration. Regional divergence appears in reimbursement schemas and regulatory pathways: the U.S. requires NRC approval for onsite cyclotrons, Europe enforces EANM guidelines, and emerging markets often depend on centralized government tenders that favor turnkey lease-to-own models.

Recent Industry Insights

```json

{

"content": [

{

"type": "paragraph",

"content": "The Positron Emission Tomography (PET) Scanners industry trends over the past 18 months have been shaped by a surge in AI-driven imaging, strategic consolidation, and a race for total-body scanners. Siemens Healthineers closed its $550 million acquisition of PET/CT developer ALARA Imaging in Q1 2024, instantly widening its total-body research footprint. Philips countered in June 2024 with a North-America-first launch of the Vereos PET/CT AI Edge, embedding FDA-cleared deep-learning reconstruction that halves tracer dose while boosting small-lesion detectability. Regulatory momentum accelerated when CMS finalised the 2025 OPPS rule, creating a separate APC for $1,950 per total-body PET study, nudging hospitals toward long-axial FOV systems. Partnerships followed: United Imaging and Radiopharm Ventures formed a 10-year exclusive to co-develop cyclotron-grade gallium-68 generators, ensuring supply chain resilience for PSMA and DOTATATE imaging. Venture money continued to flow—PositAI secured $42 million Series B for cloud-based predictive analytics that forecast patient motion, cutting repeat scans by 18 %. Together, these moves signal a pivot from hardware-centric upgrades to software-defined, theranostic-ready workflows."

}

]

}

```

Analyst Overview

The Positron Emission Tomography (PET) Scanners market outlook remains structurally attractive, underpinned by a low-double-digit revenue CAGR and entrenched clinical utility in oncology and neurology. Barriers to entry—capital intensity, regulatory hurdles, and cyclotron logistics—limit new entrants, yet competitive intensity is rising as modality-agnostic imaging giants cross-sell integrated PET-CT/MR suites. Expect margin pressure in developed regions while emerging markets offer pricing flexibility.

Long-term demand will outpace supply; only three global isotope producers control >80 % of 18F-FDG capacity, creating intermittent shortages that favor vertically integrated players. Innovation is shifting toward digital photon-counting detectors and AI-based reconstruction, compressing scan time 30–40 % and opening outpatient workflows. Key risks include reimbursement clawbacks, radiopharmaceutical price volatility, and geopolitically fragile isotope logistics; investors should underwrite scenarios where Congress reduces CMS technical payments by 5–10 % and model supply-chain resiliency premiums.

12 items

1. Executive Summary

2. Positron Emission Tomography (PET) Scanners Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Positron Emission Tomography (PET) Scanners Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Positron Emission Tomography (PET) Scanners Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Positron Emission Tomography (PET) Scanners Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Positron Emission Tomography (PET) Scanners Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Positron Emission Tomography (PET) Scanners Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Positron Emission Tomography (PET) Scanners Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Positron Emission Tomography (PET) Scanners Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Positron Emission Tomography (PET) Scanners Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Positron Emission Tomography (PET) Scanners Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Positron Emission Tomography (PET) Scanners Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Positron Emission Tomography (PET) Scanners Market Competition by Key Manufacturers

9.1. Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Positron Emission Tomography (PET) Scanners: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GE Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Siemens Healthineers

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Koninklijke Philips N.V

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Toshiba Corporation

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shimadzu Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hitachi Medical Corporation

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Fujifilm Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Neusoft Medical Systems

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Sunny Medical Equipment

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Nanjing Foinoe Co

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Yangzhou Kindsway Biotech

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Mindray Medical International

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Shenzhen Anke High-Tech

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Positron Emission Tomography (PET) Scanners Market

Figure 4: Global Positron Emission Tomography (PET) Scanners Market: Drivers

Figure 5: Global Positron Emission Tomography (PET) Scanners Market: Challenges

Figure 6: Global Positron Emission Tomography (PET) Scanners Market: Trends

Figure 7: Global Positron Emission Tomography (PET) Scanners Market: Opportunity

Figure 8: Global Positron Emission Tomography (PET) Scanners Market: Restraint

Figure 9: Global Positron Emission Tomography (PET) Scanners Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Figure 19: Global Positron Emission Tomography (PET) Scanners Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Figure 27: Global Positron Emission Tomography (PET) Scanners Market Share (%) By: Regions (2032)

Figure 28: Global Positron Emission Tomography (PET) Scanners Market Volume (K) By Region

Figure 29: Global Positron Emission Tomography (PET) Scanners Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Figure 37: Global Positron Emission Tomography (PET) Scanners Market Share (%) By: Regions (2032)

Figure 38: Global Positron Emission Tomography (PET) Scanners Market Volume (K) By Region

Figure 39: Global Positron Emission Tomography (PET) Scanners Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Positron Emission Tomography (PET) Scanners Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Table 14: Global Positron Emission Tomography (PET) Scanners Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Positron Emission Tomography (PET) Scanners Market Volume (K) By Region

Table 31: Global Positron Emission Tomography (PET) Scanners Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Positron Emission Tomography (PET) Scanners Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Positron Emission Tomography (PET) Scanners Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Positron Emission Tomography (PET) Scanners Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GE Healthcare Basic Information And Sales Area

Table 52: GE Healthcare. Products Portfolio

Table 53: Siemens Healthineers Basic Information And Sales Area

Table 54: Siemens Healthineers. Products Portfolio

Table 55: Koninklijke Philips N.V Basic Information And Sales Area

Table 56: Koninklijke Philips N.V. Products Portfolio

Table 57: Toshiba Corporation Basic Information And Sales Area

Table 58: Toshiba Corporation. Products Portfolio

Table 59: Shimadzu Corporation Basic Information And Sales Area

Table 60: Shimadzu Corporation. Products Portfolio

Table 61: Hitachi Medical Corporation Basic Information And Sales Area

Table 62: Hitachi Medical Corporation. Products Portfolio

Table 63: Fujifilm Corporation Basic Information And Sales Area

Table 64: Fujifilm Corporation. Products Portfolio

Table 65: Neusoft Medical Systems Basic Information And Sales Area

Table 66: Neusoft Medical Systems. Products Portfolio

Table 67: Sunny Medical Equipment Basic Information And Sales Area

Table 68: Sunny Medical Equipment. Products Portfolio

Table 69: Nanjing Foinoe Co Basic Information And Sales Area

Table 70: Nanjing Foinoe Co. Products Portfolio

Table 71: Yangzhou Kindsway Biotech Basic Information And Sales Area

Table 72: Yangzhou Kindsway Biotech. Products Portfolio

Table 73: Mindray Medical International Basic Information And Sales Area

Table 74: Mindray Medical International. Products Portfolio

Table 75: Shenzhen Anke High-Tech Basic Information And Sales Area

Table 76: Shenzhen Anke High-Tech. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Type

Table 82: Global Market Share (%) By Type (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Positron Emission Tomography (PET) Scanners Market Value (USD Million) By Region

Table 86: Global Positron Emission Tomography (PET) Scanners Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Type

Table 89: North America Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Type

Table 92: Europe Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Type

Table 98: South America Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 102: Global Positron Emission Tomography (PET) Scanners Market Volume (K) By Region

Table 103: Global Positron Emission Tomography (PET) Scanners Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Type

Table 106: North America Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Type

Table 109: Europe Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Type

Table 115: South America Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

FAQs

1. What is the current Positron Emission Tomography (PET) Scanners market size?

Global Positron Emission Tomography (PET) Scanners market size surpassed USD 1.1 billion in 2023, propelled by rising oncologic imaging demand and replacement of aging systems across major hospitals.

2. What is the forecast growth rate for the PET scanners market?

Analysts project a 6.2% CAGR through 2030, lifting the future outlook to roughly USD 1.7 billion as therapeutic precision medicine expands and emerging economies widen access.

3. Which factors are the primary growth drivers?

Key drivers include escalating cancer prevalence, reimbursement for amyloid brain imaging, continuous reimbursement in cardiology, and technological shift toward digital silicon photomultiplier detectors that boost throughput.

4. What challenges constrain faster adoption?

High capital outlay, cyclotron radiopharmacy logistics, limited half-life of tracers, radiologist shortages, and stringent radiation licensing collectively temper fleet expansion outside tier-1 cities.

5. Which region leads PET scanner installations?

North America commands over 42% share, driven by CMS coverage, robust clinical trials, and early uptake of total-body systems, while China and India record double-digit demand spikes.

6. Who are the top companies shaping the competitive landscape?

Siemens Healthineers, GE Healthcare, Philips, United Imaging, and Shimadzu dominate through broad portfolios, hybrid PET/CT & PET/MR suites, AI reconstruction, and global service networks ensuring high uptime.

7. Where are the biggest future opportunities?

Portable bedside scanners, theranostic partnerships pairing diagnostics with radioligand therapy, and subscription-based scanner-leasing models in Latin America and ASEAN create untapped revenue streams.

8. How is technology impacting scanner performance?

Solid-state digital detectors cut scan time 50%, AI-driven motion correction enhances resolution to 2 mm, and cloud-based reconstruction slashes capital expenditure, accelerating replacement cycles.

9. What does the regulatory landscape look like?

FDA 510(k) clearances emphasize dose-reduction software, while Europe’s MDR demands post-market tracer surveillance; several Asia-Pacific markets now fast-track approvals for Made-in-China systems.

10. Is reimbursement expansion expected to influence market dynamics?

Yes, expanding Medicare coverage for Alzheimer’s beta-amyloid imaging and proposed bundled payments for prostate cancer theranostics are poised to shorten hospital payback periods below three years.

Contact for Full Report

Loading report content...

Positron Emission Tomography (PET) Scanners Growth, Trends & Forecast Outlook 2033

Market Snapshot

Positron Emission Tomography (PET) Scanners Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Positron Emission Tomography (PET) Scanners Segmentation

Positron Emission Tomography (PET) Scanners Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Positron Emission Tomography (PET) Scanners market size?

2. What is the forecast growth rate for the PET scanners market?

3. Which factors are the primary growth drivers?

4. What challenges constrain faster adoption?

5. Which region leads PET scanner installations?

6. Who are the top companies shaping the competitive landscape?

7. Where are the biggest future opportunities?

8. How is technology impacting scanner performance?

9. What does the regulatory landscape look like?

10. Is reimbursement expansion expected to influence market dynamics?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Positron Emission Tomography (PET) Scanners Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Positron Emission Tomography (PET) Scanners Segmentation

Positron Emission Tomography (PET) Scanners Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Positron Emission Tomography (PET) Scanners market size?

2. What is the forecast growth rate for the PET scanners market?

3. Which factors are the primary growth drivers?

4. What challenges constrain faster adoption?

5. Which region leads PET scanner installations?

6. Who are the top companies shaping the competitive landscape?

7. Where are the biggest future opportunities?

8. How is technology impacting scanner performance?

9. What does the regulatory landscape look like?

10. Is reimbursement expansion expected to influence market dynamics?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation